SecBot SecBot

EVAX

Evaxion A/S
Nasdaq· Biological Products, (No Diagnostic Substances)· Inc. G7· CIK 0001828253 Biotech & Drug Discovery
$2.77 +0.03 (+1.09%)
Nov 16 4:00 PM ET · prev $2.74
Market cap
$25.5M
Nano cap
Median target
$12.00
+333% · range $9.00–16.00
Next earnings
Nov 19
in 2 days · EPS est. −$0.01
1 year
−46.8%
from $5.21 · Nov 17
30 days
−16.8%
from $3.33
52-week range
$2.74–6.63
−58% from high · low Nov 13
Avg volume 20D
114.9K
Oct 20 spike 530.2K
Short interest
27.6K
≈0.3% of shares · −58.9%
Days to cover
1.0
at average volume
New fund stakes
0
Q3 2026 13F · 0 exits
Filing reports
30
analyzed by SecBot
SecBot read MIXED 18 reports · 90 days
Balance 1 bearish · 2 bullish · 15 neutral oldest → newest, height = score
Avg score ·High conf. 12/18 ·Next Earnings date, Nov 19, 2026

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InstitutionsMIXED

    Q3 2026: 1 added (0 new), 1 trimmed or exited.

  • EstimatesFLAT

    Current-quarter EPS estimate −$0.010 → −$0.010 over 90 days.

  • Short sellersCOVERING

    Short interest −58.9% to 27.6K shares. 1.0 days to cover, ≈0.3% of shares.

  • TrendDOWNTREND

    11% below its 50-day average. New closing low $2.74 on Nov 13.

  • SocialQUIET

    No Reddit mentions this week. Last mention Nov 3.

Who's buying

13F· Q3 2026
0
new positions
0
exits
FundMoveSharesValue
RENAISSANCE TECHNOLOGIES LLCADD46,200$151.5K
UBS Group AGNEAR_EXIT937$3.1K
CITADEL ADVISORS LLCDOUBLED36,584$113.4K
RHUMBLINE ADVISERSDOUBLED21,090$100.6K
UBS Group AGDOUBLED3,217$15.3K
UBS Group AGNEAR_EXIT1$4.00
RHUMBLINE ADVISERSDOUBLED9,435$23.1K
UBS Group AGTRIM2,039$5.0K

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

Last action Apr 2026
12-month targets · 4 analysts

Price is below the lowest target. Median implies +333%.Targets as of Nov 17, 2026.

Recent actions
DateFirmActionRating
Apr 24, 2026HC Wainwright & Co.
REITERATE
REITERATEBuy
Mar 10, 2026Jones Trading
INITIATE
INITIATEBuy
Mar 9, 2026Lake Street
MAINTAIN
MAINTAINBuy
Mar 9, 2026HC Wainwright & Co.
REITERATE
REITERATEBuy
Oct 30, 2025Edward Jones
INITIATE
INITIATEBuy
Oct 20, 2025Lake Street
MAINTAIN
MAINTAINBuy

Earnings setup

Estimates
Nov 19
reports in 2 days
−$0.01
EPS estimate, this quarter
0%
estimate change, 90 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q-$0.01-$0.01–-$0.01+0.0%$0.00
Next Q-$0.01-$0.01–-$0.01+0.0%$0.00
Current FY-$0.04-$0.04–-$0.04+0.0%$0.00
Next FY-$0.01-$0.03–$0.00+0.0%$4.7M
Reddit
Recent posts
All social signals and their track records

Short side

FINRA· Oct 30, 2026
27,571
shares short
-58.9%
vs prior settlement
1.0
days to cover
≈0.3%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Recent

SecBot reports

30 filings · 20 press releases · 6 bullish · 1 bearish · 23 neutral
All EVAX filing & press-release reports (50)